» Authors » Guan-Jhou Chen

Guan-Jhou Chen

Explore the profile of Guan-Jhou Chen including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 41
Citations 246
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Lin C, Tsai C, Sun H, Huang Y, Lin K, Liu W, et al.
J Microbiol Immunol Infect . 2025 Feb; PMID: 39948011
Background: Chlamydia trachomatis infection is one of the most common sexually transmitted infections (STIs). This study investigated the prevalence and genotype distribution of C. trachomatis, and treatment response, focusing on...
2.
Chen G, Huang Y, Lin K, Sun H, Hsieh S, Sheng W, et al.
Infect Dis Ther . 2025 Feb; PMID: 39937429
Introduction: Among people with HIV (PWH), real-world data on the long-term renal function evolution while receiving tenofovir alafenamide (TAF)-containing antiretroviral therapy (ART) remain scarce. Methods: PWH who initiated or were...
3.
Huang S, Huang H, Ku S, Kuo P, Lin K, Chen G, et al.
J Microbiol Immunol Infect . 2024 Nov; 58(1):7-16. PMID: 39562191
We review the epidemiology, policies, and control programs of HIV infection in Taiwan in the past 40 years since the first case of HIV infection was diagnosed in 1984. With...
4.
Tsai M, Sun H, Su L, Lin K, Liu W, Huang Y, et al.
J Microbiol Immunol Infect . 2024 May; 57(4):629-637. PMID: 38777653
Background: Mycoplasma genitalium is an emerging etiology of sexually transmitted infections (STIs) with increasing resistance to antimicrobials. Surveillance on the epidemiology of M. genitalium infection and antimicrobial resistance is warranted....
5.
Chen G, Cheng C, Yang C, Lee N, Tang H, Huang S, et al.
J Antimicrob Chemother . 2024 Mar; 79(5):1157-1163. PMID: 38546761
Background: Monitoring the trends of pre-treatment drug resistance (PDR) and resistance-associated mutations (RAMs) among antiretroviral-naïve people with HIV (PWH) is important for the implementation of HIV treatment and control programmes....
6.
7.
Huang C, Chen G, Hung C, Yu M
J Infect Dis . 2023 Sep; 228(Suppl 3):S168-S179. PMID: 37703340
The World Health Organization has set tremendous goals to eliminate viral hepatitis by 2030. However, most countries are currently off the track for achieving these goals. Microelimination is a more...
8.
Chen G, Sun H, Chang S, Hsieh S, Sheng W, Chuang Y, et al.
J Microbiol Immunol Infect . 2023 Aug; 56(5):988-995. PMID: 37574435
Background: Antiretroviral regimens containing a second-generation integrase strand-transfer inhibitor (INSTI) plus 2 nucleos(t)ide reverse-transcriptase inhibitors (NRTIs) are the recommended therapy for people with HIV (PWH) who are antiretroviral-naïve or on...
9.
Lin K, Sun H, Huang Y, Liu W, Hsieh S, Huang S, et al.
Emerg Microbes Infect . 2023 Jul; 12(2):2239946. PMID: 37470725
Serologic responses to hepatitis A virus (HAV) vaccination may wane among immunocompromised populations. To evaluate the long-term seroresponses to 2-dose HAV vaccination, we retrospectively included people living with HIV (PLWH)...
10.
Chuang C, Hsu H, Chen G, Chuang T, Tsai M
PLoS One . 2023 Apr; 18(4):e0284564. PMID: 37053252
Background: Body weight is associated with different physiological changes and the association between weight and mortality in critical care setting had been discussed before. In this study, we investigated the...